MetaCap

DaVita (DVA) vs Sotera Health (SHC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

DaVita (DVA) has outperformed Sotera Health (SHC) over the past year, gaining 33.9% versus a loss of 2.6%. Over five years, DVA leads with a +65.5% price change compared with -26.6% for SHC. DaVita is the larger company by market cap ($10.13 billion vs $4.54 billion), about 2.2 times the size.

On valuation, DaVita trades at a lower forward P/E (9.5x vs 14.9x for Sotera Health). Sotera Health converts more of its revenue into profit, with a net margin of 6.7% versus 5.5%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

DVA+33.91%SHC-2.57%
+106%+40%-26%
Nov 21, 20251 yearNov 20, 2026
DVA+61.76%SHC-29.41%
+152%+34%-84%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

DVA versus SHC key metrics
MetricDVASHC
Share price$161.03$15.91
Market cap$10.13B$4.54B
1-day change+3.00%-1.85%
YTD return+41.74%-9.81%
1-year return+33.91%-2.57%
5-year return+65.52%-26.61%
P/E ratio (TTM)12.1926.52
Forward P/E9.5214.94
EPS (TTM)$13.21$0.60
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$13.64B$1.16B
Revenue growth (YoY)+6.46%+5.74%
Net income (latest FY)$746.80M$77.95M
Gross margin—55.48%
Operating margin14.98%—
Net margin5.47%6.70%
52-week high$247.49$19.85
52-week low$101.00$13.09
Distance from 52-week high-34.93%-19.85%
Analyst consensusbuybuy
Avg. price target upside+38.04%+34.76%
Average volume738.70K2.20M
Shares outstanding62.90M285.63M
Employees78,0003,000
SectorHealth CareHealth Care
IndustryMisc Health and Biotechnology ServicesMisc Health and Biotechnology Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • DaVita is about 2.2 times larger than Sotera Health by market value ($10.13B vs $4.54B).
  • DVA has outperformed SHC by 36.5 percentage points over the past year.
  • Sotera Health trades at a higher earnings multiple (26.5x vs 12.2x trailing P/E).

About DaVita

DVA stock →

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.

Health Care · Misc Health and Biotechnology Services · 78,000 employees

About Sotera Health

SHC stock →

Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs.

Health Care · Misc Health and Biotechnology Services · 3,000 employees

DVA vs SHC FAQ

Which is bigger, DaVita or Sotera Health?

DaVita (DVA) is larger, with a market capitalization of $10.13B compared with $4.54B for Sotera Health (SHC).

Which stock has performed better over the past year, DVA or SHC?

DVA returned +33.91% over the past 12 months, compared with -2.57% for SHC (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, DVA or SHC?

DVA has the lower trailing P/E at 12.2, versus 26.5 for SHC. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are DaVita and Sotera Health in the same industry?

Yes. Both are classified in the Misc Health and Biotechnology Services industry within the Health Care sector.

More comparisons